Laurus Labs Limited
LAURUSLABS
Rang in aandelen
#1746
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Aandeelprijs
$22.82
Marktkapitalisatie
$12.33B
Verandering (1 dag)
0.47%
Verandering (1 jaar)
123.21%
Land
IN
Handel Laurus Labs Limited (LAURUSLABS)
Categorie
Healthcare
Operationele marge voor Laurus Labs Limited (LAURUSLABS)
Operationele marge op October 2026 TTM: 21.28%
Volgens de meest recente financiële rapporten en aandelenkoers van Laurus Labs Limited is de huidige operationele marge (TTM) 21.28%. Eind 2024 had het bedrijf een operationele marge van 35.80%.
Geschiedenis van de operationele marge van Laurus Labs Limited van 2013 tot 2026
Operationele marge aan het einde van elk jaar
| Jaar | Operationele Marge | Wijzigen |
|---|---|---|
| 2026 (TTM) | 21.28% | -45.62% |
| 2025 | 39.13% | 9.30% |
| 2024 | 35.80% | 67.06% |
| 2023 | 21.43% | -11.85% |
| 2022 | 24.31% | -15.00% |
| 2021 | 28.60% | 105.90% |
| 2020 | 13.89% | 44.84% |
| 2019 | 9.59% | -34.49% |
| 2018 | 14.64% | -10.79% |
| 2017 | 16.41% | 1.99% |
| 2016 | 16.09% | 50.23% |
| 2015 | 10.71% | -29.82% |
| 2014 | 15.26% | -10.18% |
| 2013 | 16.99% | 0.00% |
Operationele marge van vergelijkbare bedrijven of concurrenten
| Bedrijf | Operationele Marge | Verschil in operationele marge | Land |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -98.92% |
IN
|
Wat is de Operationele marge van een bedrijf?
De Operationele marge is een belangrijke indicator om de winstgevendheid van een bedrijf te beoordelen. Hogere operationele marges zijn over het algemeen beter omdat ze aangeven dat een bedrijf zijn producten of diensten veel duurder kan verkopen dan de productiekosten. De Operationele marge wordt berekend door de winst van een bedrijf te delen door de omzet.